VaramirStart free · no cardSign in
XERS as of Oct 31 · 15:29 ET
XERSNasdaqPharmaceutical Preparations

Xeris Biopharma Holdings, Inc. · Brief

Next report

5 days

Nov 5 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
4 of 8≥ implied
avg implied
±16.8%
avg realized
±11.8%
Mar 6 '25±31.0%▲+9.55%×0.31
May 8 '25±15.2%▲+15.18%×1.00
Aug 7 '25±12.7%▲+20.22%×1.59
Q3 FY25±17.7%▼−21.88%×1.23
Jan 8 '26±9.4%▲+12.76%×1.36
Q1 FY26±21.8%▼−1.63%×0.07
May 7 '26±12.7%▲+4.08%×0.32
Q2 FY26±14.3%▼−9.25%×0.65
quarterimplied−35%0+35%realized×
Q2 FY26±14.3%▼−9.25%×0.65
May '26±12.7%▲+4.08%×0.32
Q1 FY26±21.8%▼−1.63%×0.07
Jan '26±9.4%▲+12.76%×1.36
Q3 FY25±17.7%▼−21.88%×1.23
Aug '25±12.7%▲+20.22%×1.59
2 older reports
May '25±15.2%▲+15.18%×1.00
Mar '25±31.0%▲+9.55%×0.31
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

11disclosed supplier and customer ties in SEC filingsSEC filings
241managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

4 of 8recent reports where the move came in under the options implied rangeEarnings history
3tracked funds holding XERSN-PORT · Aug 31 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

XERS report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±22.0% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.